A Study to Assess the Safety and Immunogenicity of PXVX0317 Chikungunya Virus Virus-Like Particle Vaccine
Clinical trial NCT05065983 · COMPLETED
Trial details
- NCT number
- NCT05065983
- Sponsor
- Bavarian Nordic
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-10-11
- Primary completion
- 2022-05-05
- Enrollment
- 25
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.